1.48
-0.02 (-1.33%)
-0.02 (-1.33%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kintara Therapeutics Inc | KTRA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.02 | -1.33% | 1.48 | 00:00:10 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 1.51 | 1.43 | 1.55 | 1.46 | 1.50 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.42 | 1.75 | 0.33 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,150 | 314,718 | $ 1.53 | $ 480,312 | 450,964 | 1.00 - 1.95 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:57:43 | formt | 200 | $ 1.48 | USD |
Kintara Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 34.84M | 23.54M | 23.15M | $ - | $ - | -0.88 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 377.82k | 7.70% |
Kintara Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KTRA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.50 | 1.60 | 1.43 | 1.50 | 158,005 | -0.02 | -1.33% |
| 1 Month | 1.33 | 1.83 | 1.3105 | 1.57 | 338,129 | 0.15 | 11.28% |
| 3 Months | 1.21 | 1.95 | 1.00 | 1.50 | 474,016 | 0.27 | 22.31% |
| 6 Months | 1.21 | 1.95 | 1.00 | 1.50 | 474,016 | 0.27 | 22.31% |
| 1 Year | 1.21 | 1.95 | 1.00 | 1.50 | 474,016 | 0.27 | 22.31% |
| 3 Years | 1.21 | 1.95 | 1.00 | 1.50 | 474,016 | 0.27 | 22.31% |
| 5 Years | 1.21 | 1.95 | 1.00 | 1.50 | 474,016 | 0.27 | 22.31% |
Kintara Therapeutics Description
| Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications. |
